Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84201-84250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05617547
Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation
N/ARecruiting
154 participants
Started: Aug 31, 2022 · Completed: Oct 1, 2024
2 conditions3 sponsors1 location
NCT05491005
The eHealth Diabetes Remission Trial
NARecruiting
106 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors3 locations
NCT05535634
Sound Ear Check (SEC) in Hearing Diagnostics in Young Children
N/ARecruiting
100 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05245786
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
EARLY_PHASE1Recruiting
15 participants
Started: Aug 31, 2022 · Completed: Nov 12, 2025
5 conditions2 sponsors1 location
NCT06173765
Understanding Dose Related Effects of Strawberry
NAActive, not recruiting
66 participants
Started: Aug 31, 2022 · Completed: Jan 28, 2026
4 conditions1 sponsor1 location
NCT05868109
Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)
PHASE2Recruiting
40 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT04711135
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
PHASE2Active, not recruiting
11 participants
Started: Aug 31, 2022 · Completed: May 7, 2034
3 conditions1 sponsor7 locations
NCT05493969
Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity
PHASE4Not yet recruiting
100 participants
Started: Aug 31, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT05461482
CLINTERVENTIONAL Trial: Impact of Clinical Consultations and Audiovisual Tools in Interventional Radiology
NARecruiting
428 participants
Started: Aug 31, 2022 · Completed: Apr 30, 2024
5 conditions1 sponsor1 location
NCT06196307
Early Warning and Classification Model for Acute Non-traumatic Chest Pain
N/ARecruiting
188 participants
Started: Aug 30, 2022 · Completed: Jan 30, 2025
1 condition1 sponsor1 location
NCT06366815
phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
N/ARecruiting
250 participants
Started: Aug 30, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor2 locations
NCT05338450
Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis
PHASE3Recruiting
80 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05500521
Association Between Severe-to-profound Hearing Loss and the Balance Function of the Inner Ear
N/AEnrolling by invitation
100 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05116475
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases
PHASE3Recruiting
152 participants
Started: Aug 30, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05508165
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NARecruiting
60 participants
Started: Aug 30, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05496491
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
NARecruiting
84 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT05428358
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
NARecruiting
200 participants
Started: Aug 30, 2022 · Completed: Dec 1, 2028
3 conditions4 sponsors4 locations
NCT05256875
An Analysis to Assess Non-adherence in People With Type 2 Diabetes
N/ARecruiting
600 participants
Started: Aug 30, 2022 · Completed: May 31, 2026
3 conditions1 sponsor2 locations
NCT05405296
Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)
N/AActive, not recruiting
1,480 participants
Started: Aug 30, 2022 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT05508438
To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment
NANot yet recruiting
140 participants
Started: Aug 30, 2022 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05587205
Study to Assess Safety and Tolerability of EO2002
PHASE1Recruiting
32 participants
Started: Aug 30, 2022 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT05456880
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
PHASE1/PHASE2Recruiting
15 participants
Started: Aug 30, 2022 · Completed: Feb 1, 2027
1 condition1 sponsor20 locations
NCT05348356
Nirogacestat in Ovarian Granulosa Cell Tumors
PHASE2Active, not recruiting
53 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor21 locations
NCT05480189
Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study
N/ANot yet recruiting
1,000 participants
Started: Aug 30, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor0 locations
NCT04877522
Asciminib Roll-over Study
PHASE4Recruiting
347 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2030
2 conditions1 sponsor83 locations
NCT05271409
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
PHASE3Recruiting
152 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors82 locations
NCT05444465
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
NARecruiting
234 participants
Started: Aug 30, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor20 locations
NCT02793492
Misago® RX Self-expanding Peripheral Stent for Common And/or External Iliac Artery
NAActive, not recruiting
75 participants
Started: Aug 30, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor9 locations
NCT05364697
IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
NAActive, not recruiting
60 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2029
4 conditions1 sponsor4 locations
NCT05240651
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
N/ARecruiting
50 participants
Started: Aug 30, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05836831
Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
PHASE4Recruiting
3,400 participants
Started: Aug 30, 2022 · Completed: Nov 30, 2026
1 condition48 sponsors48 locations
NCT05492123
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
PHASE2Recruiting
112 participants
Started: Aug 30, 2022 · Completed: Mar 31, 2028
1 condition3 sponsors14 locations
NCT06597045
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
N/AActive, not recruiting
60 participants
Started: Aug 30, 2022 · Completed: Nov 20, 2024
3 conditions3 sponsors1 location
NCT05136703
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
NARecruiting
150 participants
Started: Aug 30, 2022 · Completed: Jul 31, 2027
3 conditions2 sponsors2 locations
NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
NARecruiting
45 participants
Started: Aug 30, 2022 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT05549804
A Study of Intratumoral KL340399 in Patients with Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Aug 30, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05083182
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
PHASE3Recruiting
48 participants
Started: Aug 30, 2022 · Completed: Aug 9, 2027
1 condition1 sponsor50 locations
NCT05394103
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
PHASE1/PHASE2Recruiting
130 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2026
2 conditions2 sponsors11 locations
NCT05503251
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
PHASE2Active, not recruiting
110 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05873322
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
N/ARecruiting
100 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05149573
Investigation of PEMF Therapy for Female Patients With IC/BPS
NARecruiting
75 participants
Started: Aug 29, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05255003
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
PHASE4Recruiting
50 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2025
2 conditions1 sponsor3 locations
NCT05541380
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
N/AActive, not recruiting
300 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor9 locations
NCT05417971
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
N/ARecruiting
20 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05334888
Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach
N/ARecruiting
200 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT05433701
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
NAActive, not recruiting
178 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05341557
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
PHASE1Recruiting
110 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
4 conditions1 sponsor4 locations
NCT05377450
Prospective Randomized Study of Cementless vs Cemented UKA
NAActive, not recruiting
108 participants
Started: Aug 29, 2022 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT05534321
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
PHASE1/PHASE2Recruiting
74 participants
Started: Aug 29, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05161819
Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
NARecruiting
30 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location